Overview
If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.
Description
- Patients with nephrosis who had taken glucocorticoid for the first time were followed up, and those who had diabetes themselves were excluded.
- Regularly follow up and record information on glucocorticoid medication, medications that have an impact on blood sugar, fasting blood sugar, 2-hour postprandial blood sugar, and glycated hemoglobin.
- Notify relevant doctors of any cases of elevated blood sugar.
- The total follow-up time is 1 year.
Eligibility
Inclusion Criteria:
- Patients who need to use glucocorticoids due to the following diseases: nephrotic syndrome, Immunoglobulin A nephropathy, membranous nephropathy, Anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), systemic lupus erythematosus；
- Initial daily dose of glucocorticoids greater than or equal to 10mg of prednisolone；
Exclusion Criteria:
- Patients with diabetes；
- Those who are unable to communicate through language；
- Uremic patients；
- Unable to perform blood glucose monitoring and follow-up as required；
- Those who have used glucocorticoids within the past 3 months and have accumulated a dose of 10mg or more of prednisone；
- Participated in other clinical studies。